Internet Archive Scholar

Hypercorticism during streptozotocin diabetes and mifepristone administration: the role of cyclic adenosine monophosphate

V.G. Selyatitskaya, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia, E.D. Afonnikova, N.A. Pal`chikova, O.I. Kuz`minova, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia
2019 Biomeditsinskaya Khimiya  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (238.0 kB)
https://web.archive.org/web/20210428090604/http://pbmc.ibmc.msk.ru/scripts/loadf/load.php?aid=2019-65-4-311

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

doi:10.18097/pbmc20196504311 fatcat:chvvqzlbnfcc7cf3qdbcaufkye
Citation

V.G. Selyatitskaya, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia, E.D. Afonnikova, N.A. Pal`chikova, O.I. Kuz`minova, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia. "Hypercorticism during streptozotocin diabetes and mifepristone administration: the role of cyclic adenosine monophosphate." Biomeditsinskaya Khimiya 65.4 (2019) 311-315